The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity

Sponsor
First Affiliated Hospital of Zhejiang University
Study ID
NCT06331286
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The primary objective of this study is to investigate the effect of dulaglutide adjuvant treatment in patients with bipolar disorder with obesity, in addition to exploring the effect of GLP-1RA on cognition of bipolar disorder.

Key Dates

Start date
Sep 1, 2023
Status verified
Aug 2023
Primary completion
Dec 31, 2024
Completion
Dec 31, 2024

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: dulaglutide injection treatment group
    0.75mg Subcutaneous injection once a week for 24 weeks
  • Other: diet and exercise guidance treatment
    diet and exercise guidance treatment for 24 weeks

Primary Outcome Measure

weight [ Time Frame: Baseline, the end of Week 12 and the end of Week 24 ]

Central Contacts

Related Studies